Clinical Trial Update: Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating short-term oral iron supplementation in patients with systolic heart failure and iron-deficiency anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency Anemia

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Heart Failure, Systolic, Iron-deficiency Anemia | Phase 2, Phase 3 | Status: COMPLETED